Eric M. Ostertag
32Patents
6h-index
16Co-inventors
62Inventor score
Filing activity: Feb 25, 2010 → Jun 13, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8399643B2 | Nucleic acids encoding hyperactive PiggyBac transposases | Chemistry; Metallurgy | 19 | Active |
| US8558055B2 | Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease | Human Necessities | 12 | Active |
| US8722964B2 | Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes | Chemistry; Metallurgy | 11 | Active |
| US10513686B2 | Modified stem cell memory T cells, methods of making and methods of using same | Chemistry; Metallurgy | 7 | Active |
| US9314005B2 | Genetically modified rat models for severe combined immunodeficiency (SCID) | Chemistry; Metallurgy | 6 | Active |
| US9546382B2 | Hyperactive piggybac transposases | Chemistry; Metallurgy | 6 | Active |
| US10329543B2 | Modified stem cell memory T cells, methods of making and methods of using same | Chemistry; Metallurgy | 5 | Active |
| US8808748B2 | Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same | Human Necessities | 5 | Active |
| US10131885B2 | Hyperactive piggybac transposases | Chemistry; Metallurgy | 4 | Active |
| US9421247B2 | Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same | Human Necessities | 3 | Active |
| US10415016B2 | Modified stem cell memory T cells, methods of making and methods of using same | Chemistry; Metallurgy | 3 | Active |
| US9533027B2 | Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same | Human Necessities | 3 | Active |
| US10287559B2 | Hyperactive PiggyBac transposases | Chemistry; Metallurgy | 3 | Active |
| US11377480B2 | Inducible caspases and methods for use | Chemistry; Metallurgy | 2 | Active |
| US10415024B2 | Site-specific enzymes and methods of use | Chemistry; Metallurgy | 2 | Active |
| US11089765B2 | Genetically modified rat models for severe combined immunodeficiency (SCID) | Chemistry; Metallurgy | 2 | Active |
| US10844361B2 | Site-specific enzymes and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11802269B2 | Superpiggybac transposase compositions | Chemistry; Metallurgy | 1 | Active |
| US11718656B2 | Inducible caspases and methods for use | Chemistry; Metallurgy | 0 | Active |
| US11485959B2 | Hyperactive piggybac transposases | Chemistry; Metallurgy | 0 | Active |
| US11213594B2 | Poly(histidine)-based micelles for complexation and delivery of proteins and nucleic acids | Chemistry; Metallurgy | 0 | Active |
| US8263752B2 | Methods for separating soluble selenoglycoproteins | Human Necessities | 0 | Active |
| US11849709B2 | Genetically modified rat models for severe combined immunodeficiency (SCID) | Chemistry; Metallurgy | 0 | Active |
| US12274247B2 | Genetically modified rat models for severe combined immunodeficiency (SCID) | Chemistry; Metallurgy | 0 | Active |
| US10131634B2 | Method of treating pain | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.